QR код

Healthcare costs associated with short-acting β2-agonists in asthma: observational UK SABINA study

Background: Poor asthma control is associated with high short-acting β2-agonist (SABA) use. Aim: To assess asthma-related healthcare resource utilisation (HCRU) and medication costs associated with high versus low SABA prescriptions in the UK. Design & setting: Analysis of SABINA I (SABA use IN Asth...

Повний опис

Збережено в:
Автори: Darush Attar-Zadeh, Toby Capstick, Deborah Leese, Sofie Arnetorp, Eleni Rapsomaniki, Keith Peres Da Costa, Ekaterina Maslova, Yang Xu, Danny Gibson, Jennifer K Quint
Формат: Artigo
Мова:Inglês
Опубліковано: Royal College of General Practitioners 2023-09-01
Серія:BJGP Open
Предмети:
adrenergic beta-2 receptor agonist
asthma
emergency treatment
health care costs
prescriptions
primary health care
united kingdom
Онлайн доступ:https://bjgpopen.org/content/7/3/BJGPO.2023.0015
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси